Improved uptake and bioavailability of cinnamaldehyde via solid lipid nanoparticles for oral delivery

References

• Abuasal BS, Lucas C, Peyton B, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. 2012. Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases gamma-tocotrienol oral bioavailability. Lipids. 47(5):461–469.
   PubMed Web of Science ®Google Scholar
• Aguilera-Garrido A, Arranz E, Galvez-Ruiz MJ, Marchal JA, Galisteo-Gonzalez F, Giblin L. 2022. Solid lipid nanoparticles to improve bioaccessibility and permeability of orally administered maslinic acid. Drug Deliv. 29(1):1971–1982.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alam MA, Ahmad FJ, Amir M, Pottoo FH, Sarafroz M, Jafar M, Umar K. 2019. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol. 128:825–838.
   PubMed Web of Science ®Google Scholar
• Akbari J, Saeedi M, Ahmadi F, Hashemi SMH, Babaei A, Yaddollahi S, Rostamkalaei SS, Asare-Addo K, Nokhodchi A. 2022. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Pharm Dev Technol. 27(5):525–544.
   PubMed Web of Science ®Google Scholar
• Arana L, Bayon-Cordero L, Sarasola LI, Berasategi M, Ruiz S, Alkorta I. 2019. Solid lipid nanoparticles surface modification modulates cell internalization and improves chemotoxic treatment in an oral carcinoma cell line. Nanomaterials (Basel). 9(3):464.
   PubMedGoogle Scholar
• Banerjee S, Pillai J. 2019. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs. Expert Opin Drug Metab Toxicol. 15(6):499–515.
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Zhang N. 2009. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J Biomed Nanotechnol. 5(1):84–92.
   PubMed Web of Science ®Google Scholar
• Cai Z, Wang Y, Zhu LJ, Liu ZQ. 2010. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab. 11(2):197–207.
   PubMed Web of Science ®Google Scholar
• Du Y, Ling L, Ismail M, He W, Xia Q, Zhou W, Yao C, Li X. 2018. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery. Int J Pharm. 549(1–2):352–362.
   PubMedGoogle Scholar
• Harde H, Das M, Jain S. 2011. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv. 8(11):1407–1424.
   PubMed Web of Science ®Google Scholar
• He B, Lin P, Jia Z, Du W, Qu W, Yuan L, Dai W, Zhang H, Wang X, Wang J, et al. 2013. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials. 34(25):6082–6098.
   PubMed Web of Science ®Google Scholar
• Hong SH, Ismail IA, Kang SM, Han DC, Kwon BM. 2016. Cinnamaldehydes in cancer chemotherapy. Phytother Res. 30(5):754–767.
   PubMed Web of Science ®Google Scholar
• Hu L, Xing Q, Meng J, Shang C. 2010. Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS PharmSciTech. 11(2):582–587.
   PubMed Web of Science ®Google Scholar
• Huang Z, Wu L, Wang W, Wang W, Fu F, Zhang X, Huang Y, Pan X, Wu C. 2021. Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles. Pharm Dev Technol. 26(10):1110–1119.
   PubMed Web of Science ®Google Scholar
• Jessica Elizabeth T, Gassara F, Kouassi AP, Brar SK, Belkacemi K. 2017. Spice use in food: properties and benefits. Crit Rev Food Sci Nutr. 57(6):1078–1088.
   PubMed Web of Science ®Google Scholar
• Ji H, Tang J, Li M, Ren J, Zheng N, Wu L. 2016. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv. 23(2):459–470.
   PubMed Web of Science ®Google Scholar
• Lea T. 2015. Epithelial cell models; general introduction. In: verhoeckx K, Cotter P, Lopez-Exposito I, editors. The impact of food bioactives on health: in vitro and ex vivo models. Cham, Switzerland: Springer International Publishing; p. 95–102.
   Google Scholar
• Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. 2009. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release. 133(3):238–244.
   PubMed Web of Science ®Google Scholar
• Li C, Zhou K, Chen D, Xu W, Tao Y, Pan Y, Meng K, Shabbir MAB, Liu Q, Huang L, et al. 2019. Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin. Int J Nanomedicine. 14:1619–1631.
   PubMed Web of Science ®Google Scholar
• Ma Y, He H, Xia F, Li Y, Lu Y, Chen D, Qi J, Lu Y, Zhang W, Wu W. 2017. In vivo fate of lipid-silybin conjugate nanoparticles: implications on enhanced oral bioavailability. Nanomedicine. 13(8):2643–2654.
   PubMed Web of Science ®Google Scholar
• Mendes SJF, Sousa F, Pereira DMS, Ferro TAF, Pereira ICP, Silva BLR, Pinheiro A, Mouchrek AQS, Monteiro-Neto V, Costa SKP, et al. 2016. Cinnamaldehyde modulates LPS-induced systemic inflammatory response syndrome through TRPA1-dependent and independent mechanisms. Int Immunopharmacol. 34:60–70.
   PubMed Web of Science ®Google Scholar
• Nishihira VSK, Rubim AM, Brondani M, Dos Santos JT, Pohl AR, Friedrich JF, de Lara JD, Nunes CM, Feksa LR, Simao E, et al. 2019. In vitro and in silico protein corona formation evaluation of curcumin and capsaicin loaded-solid lipid nanoparticles. Toxicol in Vitro. 61:104598.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Hu J, Qiu X, Wu S, Guo F, Tan Y. 2022. Improved biopharmaceutical performance of antipsychotic drug using lipid nanoparticles via intraperitoneal route. Pharm Dev Technol. 27(7):853–863.
   PubMed Web of Science ®Google Scholar
• Patel M, Mundada V, Sawant K. 2019a. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies. Artif Cells Nanomed Biotechnol. 47(1):144–153.
   PubMed Web of Science ®Google Scholar
• Patel MH, Mundada VP, Sawant KK. 201b9. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Dev Ind Pharm. 45(8):1242–1257.
   PubMed Web of Science ®Google Scholar
• Pedata P, Ricci G, Malorni L, Venezia A, Cammarota M, Volpe MG, Iannaccone N, Guida V, Schiraldi C, Romano M, et al. 2019. In vitro intestinal epithelium responses to titanium dioxide nanoparticles. Food Res Int. 119:634–642.
   PubMed Web of Science ®Google Scholar
• Peng LX, Lei ZQ, Rao ZL, Yang RC, Zheng L, Fan YX, Luan F, Zeng N. 2021. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis. Phytomedicine. 93:153798.
   PubMed Web of Science ®Google Scholar
• Piazzini V, Landucci E, D'Ambrosio M, Tiozzo Fasiolo L, Cinci L, Colombo G, Pellegrini-Giampietro DE, Bilia AR, Luceri C, Bergonzi MC. 2019. Chitosan coated human serum albumin nanoparticles: a promising strategy for nose-to-brain drug delivery. Int J Biol Macromol. 129:267–280.
   PubMed Web of Science ®Google Scholar
• Reinholz J, Diesler C, Schottler S, Kokkinopoulou M, Ritz S, Landfester K, Mailander V. 2018. Protein machineries defining pathways of nanocarrier exocytosis and transcytosis. Acta Biomater. 71:432–443.
   PubMed Web of Science ®Google Scholar
• Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21(1):1–26.
   PubMed Web of Science ®Google Scholar
• Shah P, Chavda K, Vyas B, Patel S. 2021. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Deliv Transl Res. 11(3):1166–1185.
   PubMed Web of Science ®Google Scholar
• Shah MK, Madan P, Lin S. 2015. Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model. Pharm Dev Technol. 20(7):877–885.
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma R. 2018. Implications of designing a bromelain loaded enteric nanoformulation on its stability and anti-inflammatory potential upon oral administration. RSC Adv. 8(5):2541–2551.
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma S, Wadhwa J. 2019. Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder. Artif Cells Nanomed Biotechnol. 47(1):45–55.
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma V, Panda AK, Majumdar DK. 2011. Development of enteric submicron particle formulation of papain for oral delivery. Int J Nanomedicine. 6:2097–2111.
   PubMed Web of Science ®Google Scholar
• Shi LL, Cao Y, Zhu XY, Cui JH, Cao QR. 2015. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. Int J Pharm. 478(1):60–69.
   PubMedGoogle Scholar
• Silki, Sinha VR. 2018. Enhancement of in vivo efficacy and oral bioavailability of aripiprazole with solid lipid nanoparticles. AAPS PharmSciTech. 19(3):1264–1273.
   PubMed Web of Science ®Google Scholar
• Souto EB. 2009. A special issue on Lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines). J Biomed Nanotechnol. 5(4):315–316.
   PubMed Web of Science ®Google Scholar
• Swaan PW. 1998. Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways. Pharm Res. 15(6):826–834.
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Bhattacharyya A. 2019. Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability. AAPS PharmSciTech. 20(3):121.
   PubMed Web of Science ®Google Scholar
• van Breemen RB, Li Y. 2005. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol. 1(2):175–185.
   PubMedGoogle Scholar
• Vandghanooni S, Rasoulian F, Eskandani M, Akbari Nakhjavani S, Eskandani M. 2021. Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties. Pharm Dev Technol. 26(9):934–942.
   PubMed Web of Science ®Google Scholar
• Xu R, Yuan Y, Qi J, Zhou J, Guo X, Zhang J, Zhan R. 2018. Elucidation of the intestinal absorption mechanism of loganin in the human intestinal caco-2 cell model. Evid Based Complement Alternat Med. 2018:8340563.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhai B, Fan Y, Wang J, Sun J, Shi Y, Guo D. 2018. Intestinal absorption mechanisms of araloside A in situ single-pass intestinal perfusion and in vitro Caco-2 cell model. Biomed Pharmacother. 106:1563–1569.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. 2006. Self-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy. Int J Pharm. 324(2):191–198.
   PubMedGoogle Scholar
• Zhao B, Gu S, Du Y, Shen M, Liu X, Shen Y. 2018. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. Int J Pharm. 535(1–2):164–171.
   PubMed Web of Science ®Google Scholar
• Zhou F, Huang W, Li M, Zhong Y, Wang M, Lu B. 2018. Bioaccessibility and absorption mechanism of phenylethanoid glycosides using simulated digestion/Caco-2 intestinal cell models. J Agric Food Chem. 66(18):4630–4637.
   PubMed Web of Science ®Google Scholar
• Zuo J, Zhao D, Yu N, Fang X, Mu Q, Ma Y, Mo F, Wu R, Ma R, Wang L, et al. 2017. Cinnamaldehyde ameliorates diet-induced obesity in mice by inducing browning of white adipose tissue. Cell Physiol Biochem. 42(4):1514–1525.
   PubMedGoogle Scholar